Effectiveness of sodium hyaluronate (Protad) application in endoscopic endonasal dacryocystorhinostomy
Abstract Objective To evaluate the effects of applying sodium hyaluronate solution (Protad) intraoperatively during endonasal dacryocystorhinostomy. Methods A retrospective medical record review of all 254 patients (254 eyes) who underwent endonasal dacryocystorhinostomy for nasolacrimal duct obstru...
Gespeichert in:
Veröffentlicht in: | Canadian journal of ophthalmology 2017-04, Vol.52 (2), p.192-197 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 197 |
---|---|
container_issue | 2 |
container_start_page | 192 |
container_title | Canadian journal of ophthalmology |
container_volume | 52 |
creator | Park, Jinhwan, MD Lee, Joonsik, MD, PhD Jang, Sungmin, MD Lee, Hwa, MD, PhD Chang, Minwook, MD, PhD Park, Minsoo, MD, PhD Baek, Sehyun, MD, PhD |
description | Abstract Objective To evaluate the effects of applying sodium hyaluronate solution (Protad) intraoperatively during endonasal dacryocystorhinostomy. Methods A retrospective medical record review of all 254 patients (254 eyes) who underwent endonasal dacryocystorhinostomy for nasolacrimal duct obstruction was performed. The success rates and postoperative complications of the Protad application group (105 eyes) and the control group (149 eyes) were compared. Results The Protad group had better anatomical (96.2% vs 86.6%, p = 0.010) and functional (93.3% vs 85.2%, p = 0.046) surgical success rates. Granuloma developed less frequently in the Protad group (11.4% vs 32.9%, p < 0.001). Regarding secondary outcomes, synechia was less frequent in the Protad group, but the difference was not statistically significant ( p = 0.283). Crust and infection rates were also lower in the Protad group (6.7% vs 11.4% for crust, 7.6% vs 8.1% for infection), but the difference was not statistically significant ( p = 0.203 and p = 0.899, respectively). The rate of revision surgery was significantly lower in the Protad group compared to the control group (1.9% vs 14.1%, p < 0.001). Granuloma had the largest effects on anatomical and functional surgical success (odds ratio, 72.221 for anatomical and 19.915 for functional). Conclusions The application of Protad effectively reduced postoperative granulation and enhanced surgical success rate after endonasal dacryocystorhinostomy. We suggest that Protad is a good nasal dressing material, especially for beginners in endoscopic surgery who work on Asian patients with narrow nasal cavities. |
doi_str_mv | 10.1016/j.jcjo.2016.08.010 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1893970491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0008418215300855</els_id><sourcerecordid>1893970491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-7260cb6ba629008b1c749f0e3376e5f6591619a0860efea7c206766b22d0ac2d3</originalsourceid><addsrcrecordid>eNp9kcFu1jAQhC1ERf8WXoADyrEckq6dxEkkhFRVpSBVaiXgbDn2WnVI7GAnlfL2OPyFAwdOO4eZ0e63hLylUFCg_HIoBjX4giVdQFsAhRfkQBta52XJ4SU5AECbV7Rlp-QsxgGgLJuKvyKnrK3qhnVwIObGGFSLfUKHMWbeZNFru07Z4ybHNXgnF8wuHoJfpH6fyXkerZKL9S6zLkOnfVR-tuq3dDLKMdNShc2rLS4-PFrn05y21-TEyDHim-d5Tr5_uvl2_Tm_u7_9cn11l6uK0iVvGAfV817ytBy0PVVN1RnAtDfH2vC6o5x2EloOaFA2igFvOO8Z0yAV0-U5uTj2zsH_XDEuYrJR4ThKh36NgrZd2TVQdTRZ2dGqgo8xoBFzsJMMm6Agdr5iEDtfsfMV0IrEN4XePfev_YT6b-QP0GT4cDRguvLJYhBRWXQKtQ2Js9De_r__4z9xNVqXkI8_cMM4-DW4xE9QEZkA8XX_8P5gWpdJ1XX5CzeoolM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1893970491</pqid></control><display><type>article</type><title>Effectiveness of sodium hyaluronate (Protad) application in endoscopic endonasal dacryocystorhinostomy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Park, Jinhwan, MD ; Lee, Joonsik, MD, PhD ; Jang, Sungmin, MD ; Lee, Hwa, MD, PhD ; Chang, Minwook, MD, PhD ; Park, Minsoo, MD, PhD ; Baek, Sehyun, MD, PhD</creator><creatorcontrib>Park, Jinhwan, MD ; Lee, Joonsik, MD, PhD ; Jang, Sungmin, MD ; Lee, Hwa, MD, PhD ; Chang, Minwook, MD, PhD ; Park, Minsoo, MD, PhD ; Baek, Sehyun, MD, PhD</creatorcontrib><description>Abstract Objective To evaluate the effects of applying sodium hyaluronate solution (Protad) intraoperatively during endonasal dacryocystorhinostomy. Methods A retrospective medical record review of all 254 patients (254 eyes) who underwent endonasal dacryocystorhinostomy for nasolacrimal duct obstruction was performed. The success rates and postoperative complications of the Protad application group (105 eyes) and the control group (149 eyes) were compared. Results The Protad group had better anatomical (96.2% vs 86.6%, p = 0.010) and functional (93.3% vs 85.2%, p = 0.046) surgical success rates. Granuloma developed less frequently in the Protad group (11.4% vs 32.9%, p < 0.001). Regarding secondary outcomes, synechia was less frequent in the Protad group, but the difference was not statistically significant ( p = 0.283). Crust and infection rates were also lower in the Protad group (6.7% vs 11.4% for crust, 7.6% vs 8.1% for infection), but the difference was not statistically significant ( p = 0.203 and p = 0.899, respectively). The rate of revision surgery was significantly lower in the Protad group compared to the control group (1.9% vs 14.1%, p < 0.001). Granuloma had the largest effects on anatomical and functional surgical success (odds ratio, 72.221 for anatomical and 19.915 for functional). Conclusions The application of Protad effectively reduced postoperative granulation and enhanced surgical success rate after endonasal dacryocystorhinostomy. We suggest that Protad is a good nasal dressing material, especially for beginners in endoscopic surgery who work on Asian patients with narrow nasal cavities.</description><identifier>ISSN: 0008-4182</identifier><identifier>EISSN: 1715-3360</identifier><identifier>DOI: 10.1016/j.jcjo.2016.08.010</identifier><identifier>PMID: 28457290</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adjuvants, Immunologic - administration & dosage ; Administration, Topical ; Dacryocystorhinostomy - methods ; Female ; Follow-Up Studies ; Humans ; Hyaluronic Acid - administration & dosage ; Internal Medicine ; Intraoperative Period ; Lacrimal Duct Obstruction - diagnosis ; Lacrimal Duct Obstruction - therapy ; Male ; Middle Aged ; Nasolacrimal Duct - surgery ; Natural Orifice Endoscopic Surgery - methods ; Ophthalmology ; Postoperative Complications - prevention & control ; Retrospective Studies ; Treatment Outcome</subject><ispartof>Canadian journal of ophthalmology, 2017-04, Vol.52 (2), p.192-197</ispartof><rights>Canadian Ophthalmological Society</rights><rights>2017 Canadian Ophthalmological Society</rights><rights>Copyright © 2017 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-7260cb6ba629008b1c749f0e3376e5f6591619a0860efea7c206766b22d0ac2d3</citedby><cites>FETCH-LOGICAL-c411t-7260cb6ba629008b1c749f0e3376e5f6591619a0860efea7c206766b22d0ac2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jcjo.2016.08.010$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28457290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Park, Jinhwan, MD</creatorcontrib><creatorcontrib>Lee, Joonsik, MD, PhD</creatorcontrib><creatorcontrib>Jang, Sungmin, MD</creatorcontrib><creatorcontrib>Lee, Hwa, MD, PhD</creatorcontrib><creatorcontrib>Chang, Minwook, MD, PhD</creatorcontrib><creatorcontrib>Park, Minsoo, MD, PhD</creatorcontrib><creatorcontrib>Baek, Sehyun, MD, PhD</creatorcontrib><title>Effectiveness of sodium hyaluronate (Protad) application in endoscopic endonasal dacryocystorhinostomy</title><title>Canadian journal of ophthalmology</title><addtitle>Can J Ophthalmol</addtitle><description>Abstract Objective To evaluate the effects of applying sodium hyaluronate solution (Protad) intraoperatively during endonasal dacryocystorhinostomy. Methods A retrospective medical record review of all 254 patients (254 eyes) who underwent endonasal dacryocystorhinostomy for nasolacrimal duct obstruction was performed. The success rates and postoperative complications of the Protad application group (105 eyes) and the control group (149 eyes) were compared. Results The Protad group had better anatomical (96.2% vs 86.6%, p = 0.010) and functional (93.3% vs 85.2%, p = 0.046) surgical success rates. Granuloma developed less frequently in the Protad group (11.4% vs 32.9%, p < 0.001). Regarding secondary outcomes, synechia was less frequent in the Protad group, but the difference was not statistically significant ( p = 0.283). Crust and infection rates were also lower in the Protad group (6.7% vs 11.4% for crust, 7.6% vs 8.1% for infection), but the difference was not statistically significant ( p = 0.203 and p = 0.899, respectively). The rate of revision surgery was significantly lower in the Protad group compared to the control group (1.9% vs 14.1%, p < 0.001). Granuloma had the largest effects on anatomical and functional surgical success (odds ratio, 72.221 for anatomical and 19.915 for functional). Conclusions The application of Protad effectively reduced postoperative granulation and enhanced surgical success rate after endonasal dacryocystorhinostomy. We suggest that Protad is a good nasal dressing material, especially for beginners in endoscopic surgery who work on Asian patients with narrow nasal cavities.</description><subject>Adjuvants, Immunologic - administration & dosage</subject><subject>Administration, Topical</subject><subject>Dacryocystorhinostomy - methods</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hyaluronic Acid - administration & dosage</subject><subject>Internal Medicine</subject><subject>Intraoperative Period</subject><subject>Lacrimal Duct Obstruction - diagnosis</subject><subject>Lacrimal Duct Obstruction - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nasolacrimal Duct - surgery</subject><subject>Natural Orifice Endoscopic Surgery - methods</subject><subject>Ophthalmology</subject><subject>Postoperative Complications - prevention & control</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>0008-4182</issn><issn>1715-3360</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcFu1jAQhC1ERf8WXoADyrEckq6dxEkkhFRVpSBVaiXgbDn2WnVI7GAnlfL2OPyFAwdOO4eZ0e63hLylUFCg_HIoBjX4giVdQFsAhRfkQBta52XJ4SU5AECbV7Rlp-QsxgGgLJuKvyKnrK3qhnVwIObGGFSLfUKHMWbeZNFru07Z4ybHNXgnF8wuHoJfpH6fyXkerZKL9S6zLkOnfVR-tuq3dDLKMdNShc2rLS4-PFrn05y21-TEyDHim-d5Tr5_uvl2_Tm_u7_9cn11l6uK0iVvGAfV817ytBy0PVVN1RnAtDfH2vC6o5x2EloOaFA2igFvOO8Z0yAV0-U5uTj2zsH_XDEuYrJR4ThKh36NgrZd2TVQdTRZ2dGqgo8xoBFzsJMMm6Agdr5iEDtfsfMV0IrEN4XePfev_YT6b-QP0GT4cDRguvLJYhBRWXQKtQ2Js9De_r__4z9xNVqXkI8_cMM4-DW4xE9QEZkA8XX_8P5gWpdJ1XX5CzeoolM</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Park, Jinhwan, MD</creator><creator>Lee, Joonsik, MD, PhD</creator><creator>Jang, Sungmin, MD</creator><creator>Lee, Hwa, MD, PhD</creator><creator>Chang, Minwook, MD, PhD</creator><creator>Park, Minsoo, MD, PhD</creator><creator>Baek, Sehyun, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Effectiveness of sodium hyaluronate (Protad) application in endoscopic endonasal dacryocystorhinostomy</title><author>Park, Jinhwan, MD ; Lee, Joonsik, MD, PhD ; Jang, Sungmin, MD ; Lee, Hwa, MD, PhD ; Chang, Minwook, MD, PhD ; Park, Minsoo, MD, PhD ; Baek, Sehyun, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-7260cb6ba629008b1c749f0e3376e5f6591619a0860efea7c206766b22d0ac2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adjuvants, Immunologic - administration & dosage</topic><topic>Administration, Topical</topic><topic>Dacryocystorhinostomy - methods</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hyaluronic Acid - administration & dosage</topic><topic>Internal Medicine</topic><topic>Intraoperative Period</topic><topic>Lacrimal Duct Obstruction - diagnosis</topic><topic>Lacrimal Duct Obstruction - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nasolacrimal Duct - surgery</topic><topic>Natural Orifice Endoscopic Surgery - methods</topic><topic>Ophthalmology</topic><topic>Postoperative Complications - prevention & control</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Park, Jinhwan, MD</creatorcontrib><creatorcontrib>Lee, Joonsik, MD, PhD</creatorcontrib><creatorcontrib>Jang, Sungmin, MD</creatorcontrib><creatorcontrib>Lee, Hwa, MD, PhD</creatorcontrib><creatorcontrib>Chang, Minwook, MD, PhD</creatorcontrib><creatorcontrib>Park, Minsoo, MD, PhD</creatorcontrib><creatorcontrib>Baek, Sehyun, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Canadian journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Jinhwan, MD</au><au>Lee, Joonsik, MD, PhD</au><au>Jang, Sungmin, MD</au><au>Lee, Hwa, MD, PhD</au><au>Chang, Minwook, MD, PhD</au><au>Park, Minsoo, MD, PhD</au><au>Baek, Sehyun, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of sodium hyaluronate (Protad) application in endoscopic endonasal dacryocystorhinostomy</atitle><jtitle>Canadian journal of ophthalmology</jtitle><addtitle>Can J Ophthalmol</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>52</volume><issue>2</issue><spage>192</spage><epage>197</epage><pages>192-197</pages><issn>0008-4182</issn><eissn>1715-3360</eissn><abstract>Abstract Objective To evaluate the effects of applying sodium hyaluronate solution (Protad) intraoperatively during endonasal dacryocystorhinostomy. Methods A retrospective medical record review of all 254 patients (254 eyes) who underwent endonasal dacryocystorhinostomy for nasolacrimal duct obstruction was performed. The success rates and postoperative complications of the Protad application group (105 eyes) and the control group (149 eyes) were compared. Results The Protad group had better anatomical (96.2% vs 86.6%, p = 0.010) and functional (93.3% vs 85.2%, p = 0.046) surgical success rates. Granuloma developed less frequently in the Protad group (11.4% vs 32.9%, p < 0.001). Regarding secondary outcomes, synechia was less frequent in the Protad group, but the difference was not statistically significant ( p = 0.283). Crust and infection rates were also lower in the Protad group (6.7% vs 11.4% for crust, 7.6% vs 8.1% for infection), but the difference was not statistically significant ( p = 0.203 and p = 0.899, respectively). The rate of revision surgery was significantly lower in the Protad group compared to the control group (1.9% vs 14.1%, p < 0.001). Granuloma had the largest effects on anatomical and functional surgical success (odds ratio, 72.221 for anatomical and 19.915 for functional). Conclusions The application of Protad effectively reduced postoperative granulation and enhanced surgical success rate after endonasal dacryocystorhinostomy. We suggest that Protad is a good nasal dressing material, especially for beginners in endoscopic surgery who work on Asian patients with narrow nasal cavities.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>28457290</pmid><doi>10.1016/j.jcjo.2016.08.010</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-4182 |
ispartof | Canadian journal of ophthalmology, 2017-04, Vol.52 (2), p.192-197 |
issn | 0008-4182 1715-3360 |
language | eng |
recordid | cdi_proquest_miscellaneous_1893970491 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adjuvants, Immunologic - administration & dosage Administration, Topical Dacryocystorhinostomy - methods Female Follow-Up Studies Humans Hyaluronic Acid - administration & dosage Internal Medicine Intraoperative Period Lacrimal Duct Obstruction - diagnosis Lacrimal Duct Obstruction - therapy Male Middle Aged Nasolacrimal Duct - surgery Natural Orifice Endoscopic Surgery - methods Ophthalmology Postoperative Complications - prevention & control Retrospective Studies Treatment Outcome |
title | Effectiveness of sodium hyaluronate (Protad) application in endoscopic endonasal dacryocystorhinostomy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T11%3A24%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20sodium%20hyaluronate%20(Protad)%20application%20in%20endoscopic%20endonasal%20dacryocystorhinostomy&rft.jtitle=Canadian%20journal%20of%20ophthalmology&rft.au=Park,%20Jinhwan,%20MD&rft.date=2017-04-01&rft.volume=52&rft.issue=2&rft.spage=192&rft.epage=197&rft.pages=192-197&rft.issn=0008-4182&rft.eissn=1715-3360&rft_id=info:doi/10.1016/j.jcjo.2016.08.010&rft_dat=%3Cproquest_cross%3E1893970491%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1893970491&rft_id=info:pmid/28457290&rft_els_id=S0008418215300855&rfr_iscdi=true |